Aditxt stock.

Get Aditxt Inc (ADTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsThe latest Aditxt stock prices, stock quotes, news, and ADTX history to help you invest and trade smarter.Nov 30, 2023 · Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. Aditxt, Inc. is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops …

151.32. A high-level overview of Aditxt, Inc. (ADTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune …Aditxt stock price has plummeted: avoid at all cost. Aditxt (NASDAQ: ADTX) stock price has been in the spotlight in the past few days. The shares plunged by more than 24% on Friday, one of its worst days this year.

The reverse stock split took effect immediately as trading commenced on that day. For those interested in tracking Aditxt’s common stock, it is worth noting that after-hours trading data can be accessed through Nasdaq’s website. This provides investors with valuable insights into the stock’s performance beyond regular trading hours.Using data from Stockcharts, ADTX opened 2023 at a price of $44. Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator ...

Aditxt Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ADTX stock price.Nov 30, 2023 · Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ... Key Data. Open $3.5000. Day Range 3.3000 - 3.5765. 52 Week Range 3.2727 - 76.4000. Market Cap $1.55M. Shares Outstanding 441.85K. Public Float 189.2K. Beta 1.06. Rev. per Employee $12.29K. Stock Price History. Stock Splits. Market Cap. Historical daily share price chart and data for Aditxt since 2020 adjusted for splits and dividends. The latest closing stock price for …When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...

Long Term Solvency. A high-level overview of Aditxt, Inc. (ADTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

54,425,013. 2,056,169. 1,397,559. 1.47. Data brought to you by Benzinga APIs. Looking for the most shorted stocks? Short interest for Aditxt gives investors a sense of the degree to which ...

Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ...ADTX | Aditxt.com | Innovation in monitoring and treatment of the immune system 14 • For the quarter ended March 31, 2022 Aditxt recognized $210,279 of revenue compared to $105,034 in the year ended December 31, 2022. - - - 79 $-0 0 0 0 0 00 0 1 1 1 1 2 evenue CommercializationAditxt stock price from Google Finance. As we can see that price rise went away again and rather rapidly at that. There’s also been the reverse stock split at Aditxt: “Aditxt (NASDAQ: ADTX) stock should rise 4,000% at the open. ADTX stock also rose 32% yesterday but these are two entirely and wholly different things.Aditxt, Inc., (NASDAQ: ADTX) (' Aditxt ' or the 'Company'), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces the formation of a U.S.-based wholly- owned subsidiary, Pearsanta, Inc. ('Pearsanta'), to accelerate the growth of Aditxt's second program, AditxtScore, through future strategic revenue and ...Aditxt shares are down from a premarket high of $8.27 and are moving on very heavy trading volume. Aditxt, Inc. ADTX +31.7%. + Free Alerts. shares are blasting higher Thursday despite a lack of ...Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) was the target of a significant growth in short interest during the month of November. As of November 15th, …Stock analysis for Aditxt Inc (ADTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Sep 1, 2023 · Aditxt (NASDAQ:ADTX) stock price dipped 48% on the purchase and sale of an aggregate of 1M shares at a purchase price of $10.00 per share in a private placement priced at the market under Nasdaq ... Apr 20, 2023 · Aditxt ( NASDAQ: ADTX) signed an agreement with Cellvera to get 50% ownership in G Response Aid FZE (GRA or Global Response Aid) for $24.5M and royalties. Aditxt noted that it will partner with ... Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023 Business Wire - Aug 17, 2023, 12:00PM Full archive of press releases ...Company profile page for Aditxt Inc including stock price, company news, press releases, executives, board members, and contact informationNov 27, 2023 · Aditxt's stock was trading at $46.1840 at the beginning of 2023. Since then, ADTX shares have decreased by 92.6% and is now trading at $3.41. View the best growth stocks for 2023 here. The reverse stock split is primarily intended to bring the Company into compliance with Nasdaq’s minimum bid price requirement. Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on July 20, 2023, as amended. About Aditxt, Inc.

Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month. What To ...Using data from Stockcharts, ADTX opened 2023 at a price of $44. Therefore, even with the upswing in shares today, Aditxt’s stock is down about 58%. In addition, investment data aggregator ...

Given that Aditxt Inc has a price to book of 0.38 X, we suggest you to validate Aditxt Inc market performance and probability of bankruptcy to ensure the ...Additional information concerning the reverse stock split can be found in Aditxt’s definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2022, as amended. About Aditxt, Inc. Aditxt is a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the …4 thg 5, 2022 ... Aditxt is a biotech innovation company developing ... Current valuations suggest more cash will flow into stocks this year, says Ben Emons.As previously reported by Aditxt, Inc. (the "Company") on a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the "SEC") on July 20, 2022, the Company received a letter from the Staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") stating that the …14 giờ trước ... ADTX has a roughly average overall score of 40 meaning the stock holds a better value than 40% of stocks at its current price.Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023 Business Wire - Aug 17, 2023, 12:00PM Full archive of press releases ...Apr 15, 2023 · Aditxt's stock closed Friday at 87.49 cents per share. Pfizer's stock closed at $41.19. Amro Albanna, the co-founder, chairman and CEO of Richmond, Virginia-based Aditxt, contended that picking ... Aditxt stock is rising higher on Thursday as investors react to heavy trading of ADTX shares despite a lack of news today.More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move ...Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic ...Apr 20, 2023 · Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common ...

Nov 30, 2023 · Aditxt, Inc. (NASDAQ: ADTX) shares are blasting higher Thursday despite a lack of company-specific news. Despite today's gains, the stock remains down by more than 20% over the last month.

View today's Aditx Therapeutics Inc stock price and latest ADTX news and analysis. Create real-time notifications to follow any changes in the live stock price. ... Aditxt, Inc., a biotech company ...

Aditxt Stock Performance. Shares of ADTX stock traded down $0.11 during trading hours on Tuesday, reaching $3.44. 21,674 shares of the company’s stock were exchanged, compared to its average ...Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules. RICHMOND, Va., September 06, 2023--Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today …Aditxt, Inc. has entered into revenue-sharing agreement with Cellvera, and certain of its affiliates. The agreement is designed to drive strategic revenue and growth starting in 2022 and provide enhanced security for the Company's $14.5 million loan, plus interest to Cellvera Global Holdings LLC (“Cellvera”), formerly AiPharma Global Holdings …The purpose of this Amendment No. 1 on Form 10-K/A (the “Amendment”) is to amend and restate Part III, Items 10 through 14 of the previously filed Annual Report on Form 10-K of Aditxt, Inc. (the “Company”) for the year ended December 31, 2022, filed with the Securities and Exchange Commission on April 17, 2023 (the “Original Form 10-K”), to include information previously omitted in ...EBIT Margin. -2872.56%. -43865.44%. -. -. -. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Aditxt, Inc. (ADTX). See many years of revenue, …ADTX Stock and the Reverse Split. Yesterday afternoon, Aditxt announced that it would carry out “a 1-for-50 reverse split of its common stock” to go into effect yesterday at 4:01 pm Eastern ...On June 12, 2023, Amro Albanna, the Chief Executive Officer of Aditxt, Inc. (the "Company"), and Shahrokh Shabahang, the Chief Innovation Officer of the Company, loaned $200,000 and $100,000, respectively, to the Company. The loans were evidenced by an unsecured promissory note (the "Note").Aditxt, Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: ADTX | Nasdaq

Find the latest Aditxt, Inc. (ADTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Key Data. Open $3.5000. Day Range 3.3000 - 3.5765. 52 Week Range 3.2727 - 76.4000. Market Cap $1.55M. Shares Outstanding 441.85K. Public Float 189.2K. Beta 1.06. Rev. per Employee $12.29K.Aditxt climbs 32% postmarket after completing 1-for-50 reverse stock split SA News Tue, Sep. 13, 2022 Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidateAditxt Stock Performance. ADTX opened at $3.50 on Wednesday. Aditxt has a 12-month low of $3.27 and a 12-month high of $76.40. The stock has a fifty day moving average of $8.52 and a 200-day ...Instagram:https://instagram. 1964 kennedy half dollar worthamman exchange stockbest dental insurance for familybluepeak internet reviews Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules Business Wire - Thu Apr 20, 12:35PM CDT . Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that... ishares 7 10 year treasury bond etfamd stock.forecast The Series A warrants permit the holder to purchase one share of common stock at an exercise price of $9.00 and expire after 5 years. The Series B warrants are exercisable at $11.25 per share.Aditxt (NASDAQ:ADTX) stock is rocketing higher on Thursday despite a lack of news from the biotechnology company. There are no new press releases or filings with the Securities and Exchange ... how do i check if gold is real Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and …Aditxt’s monitoring service is based on a comprehensive evaluation of the immune response to the virus or vaccine. AditxtScore provides meaningful information to help understand one’s personal immune response to COVID and not just that of the population collectively. Learn more about what your results mean in this video. From the White ...Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools